Form 13-F position report

HIMS & HERS HEALTH INC

Reported by Foresite Capital Management V LLC

HIMS CUSIP 433000106 Manager CIK 0001792206

Reported 883,751 shares, up 145,600 (19.7%) from the prior quarter.

Reported value 2.9%; share count 19.7% vs. the prior quarter.

Added
% of reported 13F value 9.11% This manager · Q3 2026
Shares 883,751 Quarter-end amount reported
Reported value $26,326,942 Fair value at quarter end
Consecutive quarters held 23 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 11180000
2022-03-31 14428000
2022-06-30 15039000
2022-09-30 18524000
2022-12-31 25905265
2023-03-31 37035140
2023-06-30 35093781
2023-09-30 23482966
2023-12-31 34117091
2024-03-31 51465333
2024-06-30 35520550
2024-09-30 32406564
2024-12-31 22725815
2025-03-31 8071612
2025-06-30 13616577
2025-09-30 15493125
2025-12-31 8869213
2026-03-31 15324015
2026-06-30 25591695
2026-09-30 26326942

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for HIMS & HERS HEALTH INC held by Foresite Capital Management V LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 883,751 +145,600 (19.7%) 9.11% $26,326,942 2026-11-16
Q2 2026 Unchanged 738,151 0 (0.0%) 7.07% $25,591,695 2026-08-14
Q1 2026 Added 738,151 +465,000 (170.2%) 5.65% $15,324,015 2026-05-15
Q4 2025 Unchanged 273,151 0 (0.0%) 5.39% $8,869,213 2026-02-17
Q3 2025 Unchanged 273,151 0 (0.0%) 14.25% $15,493,125 2025-11-14
Q2 2025 Unchanged 273,151 0 (0.0%) 16.87% $13,616,577 2025-08-12
Q1 2025 Reduced 273,151 -666,709 (-70.9%) 9.21% $8,071,612 2025-05-15
Q4 2024 Reduced 939,860 -819,454 (-46.6%) 18.91% $22,725,815 2025-02-14
Q3 2024 Unchanged 1,759,314 0 (0.0%) 22.52% $32,406,564 2024-11-14
Q2 2024 Reduced 1,759,314 -1,567,469 (-47.1%) 22.68% $35,520,550 2024-08-13
Q1 2024 Reduced 3,326,783 -506,598 (-13.2%) 48.31% $51,465,333 2024-05-15
Q4 2023 Added 3,833,381 +100,000 (2.7%) 46.49% $34,117,091 2024-02-13
Q3 2023 Unchanged 3,733,381 0 (0.0%) 37.47% $23,482,966 2023-11-13
Q2 2023 Unchanged 3,733,381 0 (0.0%) 25.63% $35,093,781 2023-08-11
Q1 2023 Reduced 3,733,381 -308,002 (-7.6%) 27.38% $37,035,140 2023-05-12
Q4 2022 Added 4,041,383 +721,597 (21.7%) 20.12% $25,905,265 2023-02-13
Q3 2022 Unchanged 3,319,786 0 (0.0%) 14.24% $18,524,000 2022-11-14
Q2 2022 Added 3,319,786 +612,864 (22.6%) 10.51% $15,039,000 2022-08-12
Q1 2022 Added 2,706,922 +1,000,000 (58.6%) 5.89% $14,428,000 2022-05-13
Q4 2021 Added 1,706,922 +650,000 (61.5%) 2.75% $11,180,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

558 managers reported HIMS & HERS HEALTH INC for Q3 2026.

Managers reporting HIMS & HERS HEALTH INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 29,739,760 +1,036,246 0.01% $885,947,448 9 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 10,409,131 -150,183 0.01% $310,088,012 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 9,526,404 -14,980 < 0.01% $283,791,575 3 qtrs
STATE STREET CORPORATION Added 8,239,957 +94,258 < 0.01% $245,468,319 23 qtrs
Divisadero Street Capital Management LP Added 7,344,028 +1,334,523 3.79% $218,778,594 12 qtrs
MORGAN STANLEY Reduced 6,239,020 -913,478 < 0.01% $185,860,440 23 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 5,630,567 -51,265 < 0.01% $167,766,031 23 qtrs
UBS Group AG Added 4,753,288 +2,092,478 0.02% $141,600,449 17 qtrs
FMR LLC Added 4,675,376 +352,084 < 0.01% $139,279,412 18 qtrs
JPMorgan Chase & Co Reduced 4,752,356 -14,425 < 0.01% $136,717,380 22 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
883,751
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.